Delivery Order SPE2DB20D1100-SPE2DB24FC6H4

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of procainamide 1,000 mg/10 ml syringes in 10 ml sizes. The contract is a firm fixed price delivery order with a potential value of $2,386.03 and a completion date of January 26, 2024. The contract does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The delivery order, valued at $1,529.21, provides for the supply of 4,565,463,613 units of the pharmaceutical drug Procainamide 1,000 mg/2 ml. The contract has a firm fixed price pricing type and an ultimate completion date of August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,491.24 firm fixed-price delivery order is for the supply of 4,564,528,683 units of the medication Procainamide 1,000 mg/10 ml vial. The contract has an ultimate completion date of May 8, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA through December...
This federal contract award, valued at $1,679.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the procurement of Procainamide, a pharmaceutical product used for medical treatment. The contract has a firm fixed price pricing type and an ultimate completion date of December 17, 2024. Amerisourcebergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,050.22 firm-fixed-price contract is for the supply of 4565366751 - Procainamide 1,000 mg/2 ml vials. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen is a large pharmaceutical distributor that has been awarded multiple federal contracts to provide a wide range of medical commodities, including specialty medications, vaccines,...
This is a federal contract award valued at $6,292.20 made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Procainamide 1 gram/10 ml vials, a medication used for cardiac conditions. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $9,910.75 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. This contract is for the provision of 4557853033 - Procainamide 1 gram/10 mL vial with a 10 mL volume. The contract is a firm fixed price award with a completion date of July 21, 2022. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal...
This federal contract award, valued at $14,567.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the procurement of Procainamide 1 Gram/10 ML Vial 10ML, a medical product used for various medical treatments. This is a Delivery Order contract with a Firm Fixed Price pricing type, with an ultimate completion date of October 11, 2023. The contract is not...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,135.24, is for the delivery of 4,566,263,362 units of Procainamide 1,000 mg/2 ml vials. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,988.72 firm-fixed-price delivery order covers the procurement of 4,564,624,206 units of procainamide 1,000 mg/2 ml vials. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC6H4
    Delivery Order

This federal contract award, valued at $1,851.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 1,000 mg/10 mL syringes of the drug procainamide, a cardiac medication. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 10, 2024.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/8/24, 9:16 AM